FundedIQ
Biotechnology

Datavant: Funding, Investors & Team (Sep 2026)

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and sharing health data. The platform that the company offers organizes healthcare data for use in clinical trial decision-making. Its focus is on the employment of artificial intelligence to improve the clinical trial process and to improve the design and interpretation of clinical trials, helping pharmaceutical companies to manage the privacy, security, compliance, and trust required to enable safe data sharing. Travis May established Datavant in San Francisco, California in 2017.

datavant.com LinkedIn San Francisco, United States 51-100 employees Founded 2014
Big Data Biopharma Clinical Trials Data Integration Health Care Software
Total raised
$40.0M
Rounds
2
Latest
Private Equity
Sep 2026

Datavant has raised $40.0M across 2 funding rounds on record, the most recent a Private Equity announced in Sep 2026.

Datavant Company Profile and Key Stats

Total funding raised
$40.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Private Equity
Sep 2026
Employees
51-100
reported band
Founded
2014
Headquarters
San Francisco, United States
Investors on record
15
5 named below

Latest funding round on record: Sep 2026.

Datavant Funding Rounds

Date
Round
Amount
Private Equity
Undisclosed
Undisclosed round
$40.0M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Datavant raised $40.0M in an undisclosed round announced in Oct 2020.

5.9 years later, a Private Equity was announced in Sep 2026 with no disclosed amount.

Datavant Investors

Founders Fund New Mountain Capital Kohlberg Kravis Roberts & Co. Sixth Street Goldman Sachs Asset Management

15 investors are recorded in total; the 5 named above are those the record identifies.

Datavant Founders and Leadership Team

Name
Role
Contact
Kyle Armbrester
Chief Executive Officer
Locked
Travis May
CEO
Locked
Pamela Tilley
Vice President
Locked

Contact details for the Datavant team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Datavant Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,981
$7.5M

Funded Startups Like Datavant in Biotechnology and San Francisco

Companies Similar to Datavant

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…

Undisclosed round $12.0M

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Datavant Funding FAQs

What does Datavant do?

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and sharing health data. The platform that the company offers organizes healthcare data for use in clinical trial decision-making. Its focus is on the employment of artificial intelligence to improve the clinical trial process and to improve the design and interpretation of clinical trials, helping pharmaceutical companies to manage the privacy, security, compliance, and trust required to enable safe data sharing. Travis May established Datavant in San Francisco, California in 2017.

How much funding has Datavant raised?

Datavant has raised $40.0M across 2 rounds on record.

When did Datavant last raise funding?

Datavant's most recent funding round on record was announced in Sep 2026. The amount was not disclosed.

Who has invested in Datavant?

Investors on record for Datavant include Founders Fund, New Mountain Capital, Kohlberg Kravis Roberts & Co., Sixth Street, Goldman Sachs Asset Management. FundedIQ records 15 investors in total.

Who is the CEO of Datavant?

Kyle Armbrester is listed as Chief Executive Officer at Datavant.

Where is Datavant headquartered?

Datavant is based in San Francisco, California, United States.

How many employees does Datavant have?

Datavant is in the 51-100 employee band.

When was Datavant founded?

Datavant was founded in 2014.

About FundedIQ's Datavant Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Datavant is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.